Article

Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicentre, randomized controlled trial

2021-01-12

Abstract excerpt

<h4>Objective: </h4> Our aim was to evaluate the efficacy and safety of intracoronary autologous bone morrow mesenchymal stem cells (BM-MSCs) transplantation in patients with ST-segment elevation myocardial infarction (STEMI). <h4>Methods: </h4> In this randomized, single-blind, controlled trial, patients with STEMI (aged 39-76 years) were enrolled at 6 centers in Beijing (the People's Liberation Army Navy General...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ce941046-ea8a-5e38-8614-7ab0b706920e
DOI: 10.21203/rs.3.rs-54127/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicentre, randomized controlled trialDOI 10.21203/rs.3.rs-54127/v2Read

Clinical translation of mesenchymal stem cells in ischemic heart failure: Challenges and future perspectivesSemantic proximity Read

Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarctionSemantic proximity Read

Stem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future DirectionsSemantic proximity Read

Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarctionSemantic proximity Read

Bone marrow mesenchymal stem cells induced to differentiate into cardiomyocyte-like cells and their protective effects on the heart during myocardial infarctionSemantic proximity Read

Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart DiseaseSemantic proximity Read

Safety and Efficacy of Human Muse Cell-Based Product for Acute Myocardial Infarction in a First-in-Human Trial.Semantic proximity Read

The Clinical Status of Stem Cell Therapy for Ischemic CardiomyopathySemantic proximity Read

Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction TreatmentSemantic proximity Read

Mesenchymal stromal cell therapy in ischemic heart disease.Semantic proximity Read

Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy.Semantic proximity Read

Human hearts have an intrinsic regenerative potential following myocardial infarctionSemantic proximity Read